Literatur
-
1
Bochud P Y, Bonten M, Marchetti O, Calandra T.
Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based review.
Crit Care Med..
2004;
32 (11 Suppl)
S495-S512
-
2
Dellinger R P, Carlet J M, Masur H. et al .
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.
Intensive Care Med.
2004;
30
536-555
-
3
Garnacho-Montero J, Garcia-Garmendia J L, Barrero-Almodovar A. et al .
Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis.
Crit Care Med.
2003;
31
742-2751
-
4
Ibrahim E H, Sherman G, Ward S, Fraser V J, Kollef M H.
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting.
Chest.
2000;
118
146-155
-
5
Kollef M H, Rello J, Cammarata S K, Croos-Dabrera R V, Wunderink R G.
Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin.
Intensive Care Med.
2004;
30
388-394
-
6
Nseir S, DiPompeo C, Soubrier S. et al .
Firstgeneration fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit.
Crit Care Med.
2005;
33
283-289
-
7
Paul M, Benuri-Silbiger I, Soares-Weiser K, Leibovici L.
Beta-lactam monotherapy versus betaa-lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials.
BMJ.
2004;
328
668
-
8
Vogel F, Bodmann K F. und die Expertenkommission der Paul-Ehrlich-Gesellschaft .
Empfehlungen zur kalkulierten parenteralen Initialtherapie bakterieller Erkrankungen bei Erwachsenen.
Chemother J.
2004;
13
46-105
Dr. med. Thomas Ziegenfuß
Chefarzt der Abteilung für Anästhesiologie und Intensivmedizin · St. Josef Krankenhaus Moers
Asberger Straße 4 · 47441 Moers ·
eMail: thomasziegenfuss@web.de
